/Companies

Corino Therapeutics

New York, US · Founded 2016 · Delaware corporation

Find your way into Corino Therapeutics

Sign up to see every warm intro you have to Corino Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Corino Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

DD
Daniel DiPietroExecutive

Board

TM
Timothy McInerneyBoard director
JM
Jay MoorinBoard director
PB
Peter BarberBoard director

Reported raises · per SEC filings

Form D private placements

$3.5M disclosed across 1 round · 2017

▶$3.5MraisedApr 2017 · 27 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Timothy McInerneyDirector
  • Daniel DiPietroExecutive Officer, Director
  • Jay MoorinDirector
  • Peter BarberDirector
Offering amount
$5M
Amount sold
$3.5M
Sales commissions
$208.4K
Proceeds to insiders
$208.4K
Placement agents
ROTH Capital Partners, Castle Hill Capital Partners, Inc.
First sale
Apr 2017
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Corino Therapeutics raised?
Corino Therapeutics has disclosed $3.5M raised across 1 round.
Where is Corino Therapeutics headquartered?
Corino Therapeutics is headquartered in New York, US.